Mindlight medical

Advanced Technology for Brain Health


Research collaborators may connect to our LabKey research database to upload data here:

Research Database

MindLight Medical is a Delaware Public Benefit Company (PBS) dedicated to early detection and monitoring of neurological, mental, and neurodevelopmental disorders using advanced neurotechnology and informatics. As a Public Benefit Company, we are dedicated to our mission of improving brain health globally in a financially responsible and sustainable way.

William J. Bosl, Ph.D.

- MindLight Founder, is also the director of the Health Informatics program at the University of San Francisco, assistant professor of Clinical Psychology, Health Informatics, and Analytics. He was previously a faculty member at Harvard Medical School and Boston Children’s Hospital, where he first developed MindLight technology. He has a PhD from Stanford University and a PhD in Behavioral Neuroscience from Boston University School of Medicine.

Brian Bosl, PT, DPT.

– MindLight cofounder, Director of Clinical Operations and licensed Doctor of Physical Therapy at the Benioff UCSF Children’s Hospital Oakland, Sports Medicine department. Dr. Bosl completed his DPT at New York University and previously worked at the prestigious Howard Head Sports Clinics in Vail, Colorado.

Tiffini Diage, MPH

VP for Regulatory Affairs with MindLight. Diage was founder and CEO of Echelon Medical Device Manufacturing (Addis Ababa, Ethiopia), a leading provider of locally manufactured medical devices which was recently acquired by African investors. Ms. Diage has over 15 years of experience in medical device industry in the United States. As a consultant in Regulatory and Clinical Affairs, Ms. Diage has successfully launched over 15 medical devices in the US, Europe, and Japan. She has served on product development teams and implementation of medical device manufacturing in 5 separate start-up companies; resulting in successful acquisition or initial public offering. Ms. Diage holds a bachelor’s degree in Biology and MPH in healthcare economics.

Tobias Loddenkemper, MD

- is board-certified pediatrics, pediatric neurology and clinical neurophysiology, an associate professor of neurology with Harvard Medical School and an attending physician at Boston Children’s Hospital, where he is also the Director of Clinical Research. As a resident and fellow at the Cleveland Clinic, he carried out observational and interventional studies on clinical seizure manifestations and treatment. In the last 3 years at Boston Children’s Hospital, he has developed a patient oriented treatment approach and algorithms for epileptic encephalopathy patients. Dr. Loddenkemper has completed training at the Harvard School of Public Health in clinical trial design. He will serve as an advisor to MindLight.

Ken Mandl MD, MPH

- is Professor of Pediatrics at Harvard Medical School and director of the Computational Health Informatics Program at Boston Children’s Hospital. He leads the transformative national SMART Platforms initiative to design the “app store for health" and is principal investigator of the Scalable Collaborative Infrastructure for a Learning Health System across Boston hospitals. He was advisor to two Directors of the CDC and chairs the Board of Scientific Counselors of the NIH’s National Library of Medicine. Dr. Mandl is board certified in pediatrics and pediatric emergency physician. He received his doctorate in medicine from Harvard Medical School his Master of Public Health degree from the Harvard School of Public Health. He completed graduate work in medical informatics at the Massachusetts Institute of Technology.

Pascal Pfiffner, MD, Ph.D.

Dr. Pfiffner is a Research associate at the University Hospital Zurich, Lecturer in Pediatrics at Harvard Medical School and Research faculty at Boston Children’s Hospital. Dr. Pfiffner's clinical research focuses on healthcare informatics technologies that support caregivers at the point of care and leverage mobile devices for health data collection. Starting as the mobile implementation expert for the SMART on FHIR team at Harvard, the advent of Apple’s ResearchKit last year shifted Pascal’s focus towards research implementations. He was the principle architect of C3-Pro toolchain, a ResearchKit-FHIR bridge for easier integration of mobile health data with the health system, already in use in live research apps.


The MindLight Advantage


Autism

MindLight uses technology developed at Harvard medical School for early detection of autism

Concussions

Objective detection of concussions and monitoring of recovery

Brain Development and Well-baby Checkups

Integrated measurement of infant brain development and tracking over time

Screening for Atypical TBI

Early detection of atypical recovery from Traumatic brain injury(TBI) that may lead to PTSD, Major depression, anxiety and other disorders

Contact Us


MindLight Medical, PBC Walnut Creek, California, USA